Poor sarcasm, meaning 'a quick often short-term fix, then back to the battle field'.

more: This is the first time mdma treatment is leaving non-profit researchers for a corporation, and shady one (C.O.M.P.A.S.S.) Per nine unnamed psychedelic-therapy researchers/experts... "Compass Pathways has relied on conventional pharmaceutical-industry tactics that could help them dominate the field, including blocking potential rivals’ ability to purchase drugs, filing an application for a manufacturing patent, and requiring contracts that give Compass power over academics’ research and are restrictive even by pharmaceutical-industry standards." Link about split in research community. This statement explains a schism in science community over current situation: https://chacruna.net/cooperation-over-competition-statement-on-open-science-for-psychedelic-medicines-and-practices/